Publicação

The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results

Ver documento

Detalhes bibliográficos
Resumo:Introduction: We report the results of the Portuguese Registry of Hypertrophic Cardiomyopathy, an initiative that reflects the current spectrum of cardiology centers throughout the territory of Portugal. Methods: A direct invitation to participate was sent to cardiology departments. Baseline and outcome data were collected. Results: A total of 29 centers participated and 1042 patients were recruited. Four centers recruited 49% of the patients, of whom 59% were male, and mean age at diagnosis was 53±16 years. Hypertrophic cardiomyopathy (HCM) was identified as familial in 33%. The major reason for diagnosis was symptoms (53%). HCM was obstructive in 35% of cases and genetic testing was performed in 51%. Invasive septal reduction therapy was offered to 8% (23% of obstructive patients). Most patients (84%) had an estimated five-year risk of sudden death of <6%. Thirteen percent received an implantable cardioverter-defibrillator. After a median follow-up of 3.3 years (interquartile range [P25-P75] 1.3-6.5 years), 31% were asymptomatic. All-cause mortality was 1.19%/year and cardiovascular mortality 0.65%/year. The incidence of heart failure-related death was 0.25%/year, of sudden cardiac death 0.22%/year and of stroke-related death 0.04%/year. Heart failure-related death plus heart transplantation occurred in 0.27%/year and sudden cardiac death plus equivalents occurred in 0.53%/year. Conclusions: Contemporary HCM in Portugal is characterized by relatively advanced age at diagnosis, and a high proportion of invasive treatment of obstructive forms. Long-term mortality is low; heart failure is the most common cause of death followed by sudden cardiac death. However, the burden of morbidity remains considerable, emphasizing the need for diseasespecific treatments that impact the natural history of the disease.
Autores principais:Cardim, Nuno
Outros Autores:Brito, Dulce; Lopes, Luís Rocha; Freitas, António; Araújo, Carla; Belo, Adriana; Gonçalves, Lino; Mimoso, Jorge; Olivotto, Iacopo; Elliott, Perry; Madeira, Hugo
Assunto:Hypertrophic cardiomyopathy Registry Left ventricular hypertrophy Outcome
Ano:2018
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
_version_ 1863858382311522304
author Cardim, Nuno
author2 Brito, Dulce
Lopes, Luís Rocha
Freitas, António
Araújo, Carla
Belo, Adriana
Gonçalves, Lino
Mimoso, Jorge
Olivotto, Iacopo
Elliott, Perry
Madeira, Hugo
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Cardim, Nuno
Brito, Dulce
Lopes, Luís Rocha
Freitas, António
Araújo, Carla
Belo, Adriana
Gonçalves, Lino
Mimoso, Jorge
Olivotto, Iacopo
Elliott, Perry
Madeira, Hugo
author_role author
contributor_name_str_mv Repositório Científico de Acesso Aberto da ULisboa
country_str PT
creators_json_str [{\"Person.name\":\"Cardim, Nuno\"},{\"Person.name\":\"Brito, Dulce\"},{\"Person.name\":\"Lopes, Luís Rocha\"},{\"Person.name\":\"Freitas, António\"},{\"Person.name\":\"Araújo, Carla\"},{\"Person.name\":\"Belo, Adriana\"},{\"Person.name\":\"Gonçalves, Lino\"},{\"Person.name\":\"Mimoso, Jorge\"},{\"Person.name\":\"Olivotto, Iacopo\"},{\"Person.name\":\"Elliott, Perry\"},{\"Person.name\":\"Madeira, Hugo\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
datacite.creators.creator.creatorName.fl_str_mv Cardim, Nuno
Brito, Dulce
Lopes, Luís Rocha
Freitas, António
Araújo, Carla
Belo, Adriana
Gonçalves, Lino
Mimoso, Jorge
Olivotto, Iacopo
Elliott, Perry
Madeira, Hugo
datacite.date.Accepted.fl_str_mv 2018-01-01T00:00:00Z
datacite.date.available.fl_str_mv 2018-10-08T13:07:43Z
datacite.date.embargoed.fl_str_mv 2018-10-08T13:07:43Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Hypertrophic cardiomyopathy
Registry
Left ventricular hypertrophy
Outcome
datacite.titles.title.fl_str_mv The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
Registo Português de Miocardiopatia Hipertrófica : resultados globais
dc.contributor.none.fl_str_mv Repositório Científico de Acesso Aberto da ULisboa
dc.creator.none.fl_str_mv Cardim, Nuno
Brito, Dulce
Lopes, Luís Rocha
Freitas, António
Araújo, Carla
Belo, Adriana
Gonçalves, Lino
Mimoso, Jorge
Olivotto, Iacopo
Elliott, Perry
Madeira, Hugo
dc.date.Accepted.fl_str_mv 2018-01-01T00:00:00Z
dc.date.available.fl_str_mv 2018-10-08T13:07:43Z
dc.date.embargoed.fl_str_mv 2018-10-08T13:07:43Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10451/34944
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv Elsevier
dc.rights.cclincense.fl_str_mv http://creativecommons.org/licenses/by/4.0/
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Hypertrophic cardiomyopathy
Registry
Left ventricular hypertrophy
Outcome
dc.title.fl_str_mv The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
Registo Português de Miocardiopatia Hipertrófica : resultados globais
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Introduction: We report the results of the Portuguese Registry of Hypertrophic Cardiomyopathy, an initiative that reflects the current spectrum of cardiology centers throughout the territory of Portugal. Methods: A direct invitation to participate was sent to cardiology departments. Baseline and outcome data were collected. Results: A total of 29 centers participated and 1042 patients were recruited. Four centers recruited 49% of the patients, of whom 59% were male, and mean age at diagnosis was 53±16 years. Hypertrophic cardiomyopathy (HCM) was identified as familial in 33%. The major reason for diagnosis was symptoms (53%). HCM was obstructive in 35% of cases and genetic testing was performed in 51%. Invasive septal reduction therapy was offered to 8% (23% of obstructive patients). Most patients (84%) had an estimated five-year risk of sudden death of <6%. Thirteen percent received an implantable cardioverter-defibrillator. After a median follow-up of 3.3 years (interquartile range [P25-P75] 1.3-6.5 years), 31% were asymptomatic. All-cause mortality was 1.19%/year and cardiovascular mortality 0.65%/year. The incidence of heart failure-related death was 0.25%/year, of sudden cardiac death 0.22%/year and of stroke-related death 0.04%/year. Heart failure-related death plus heart transplantation occurred in 0.27%/year and sudden cardiac death plus equivalents occurred in 0.53%/year. Conclusions: Contemporary HCM in Portugal is characterized by relatively advanced age at diagnosis, and a high proportion of invasive treatment of obstructive forms. Long-term mortality is low; heart failure is the most common cause of death followed by sudden cardiac death. However, the burden of morbidity remains considerable, emphasizing the need for diseasespecific treatments that impact the natural history of the disease.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://repositorio.ulisboa.pt/bitstreams/b9b98a40-fb8e-40ee-9947-839d685cecfe/download
id ul_3af0174e1bbddaa3fc0237d4e0a359fb
identifier.url.fl_str_mv http://hdl.handle.net/10451/34944
instacron_str ul
institution Universidade de Lisboa
instname_str Universidade de Lisboa
language eng
network_acronym_str ul
network_name_str Repositório da Universidade de Lisboa
oai_identifier_str oai:repositorio.ulisboa.pt:10451/34944
organization_str_mv urn:organizationAcronym:ul
person_str_mv Cardim, Nuno
Brito, Dulce
Lopes, Luís Rocha
Freitas, António
Araújo, Carla
Belo, Adriana
Gonçalves, Lino
Mimoso, Jorge
Olivotto, Iacopo
Elliott, Perry
Madeira, Hugo
publishDate 2018
publisher.none.fl_str_mv Elsevier
reponame_str Repositório da Universidade de Lisboa
repository_id_str urn:repositoryAcronym:ul
service_str_mv urn:repositoryAcronym:ul
spelling engElsevierpt_PTIntroduction: We report the results of the Portuguese Registry of Hypertrophic Cardiomyopathy, an initiative that reflects the current spectrum of cardiology centers throughout the territory of Portugal. Methods: A direct invitation to participate was sent to cardiology departments. Baseline and outcome data were collected. Results: A total of 29 centers participated and 1042 patients were recruited. Four centers recruited 49% of the patients, of whom 59% were male, and mean age at diagnosis was 53±16 years. Hypertrophic cardiomyopathy (HCM) was identified as familial in 33%. The major reason for diagnosis was symptoms (53%). HCM was obstructive in 35% of cases and genetic testing was performed in 51%. Invasive septal reduction therapy was offered to 8% (23% of obstructive patients). Most patients (84%) had an estimated five-year risk of sudden death of <6%. Thirteen percent received an implantable cardioverter-defibrillator. After a median follow-up of 3.3 years (interquartile range [P25-P75] 1.3-6.5 years), 31% were asymptomatic. All-cause mortality was 1.19%/year and cardiovascular mortality 0.65%/year. The incidence of heart failure-related death was 0.25%/year, of sudden cardiac death 0.22%/year and of stroke-related death 0.04%/year. Heart failure-related death plus heart transplantation occurred in 0.27%/year and sudden cardiac death plus equivalents occurred in 0.53%/year. Conclusions: Contemporary HCM in Portugal is characterized by relatively advanced age at diagnosis, and a high proportion of invasive treatment of obstructive forms. Long-term mortality is low; heart failure is the most common cause of death followed by sudden cardiac death. However, the burden of morbidity remains considerable, emphasizing the need for diseasespecific treatments that impact the natural history of the disease.application/pdfpt_PTThe Portuguese Registry of Hypertrophic Cardiomyopathy : overall resultsAlternativeTitlept_PTRegisto Português de Miocardiopatia Hipertrófica : resultados globaisCardim, NunoBrito, DulceLopes, Luís RochaFreitas, AntónioAraújo, CarlaBelo, AdrianaGonçalves, LinoMimoso, JorgeOlivotto, IacopoElliott, PerryMadeira, HugoHostingInstitutionOrganizationalRepositório Científico de Acesso Aberto da ULisboae-mailmailto:repositorio@reitoria.ulisboa.ptrepositorio@reitoria.ulisboa.ptISSNIsPartOf2174-2049DOIIsPartOf10.1016/j.repce.2018.02.0082018-10-08T13:07:43Z20182018-01-01T00:00:00ZHandlehttp://hdl.handle.net/10451/34944http://purl.org/coar/access_right/c_abf2open accessHypertrophic cardiomyopathyRegistryLeft ventricular hypertrophyOutcome796492 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal article2018http://creativecommons.org/licenses/by/4.0/http://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://repositorio.ulisboa.pt/bitstreams/b9b98a40-fb8e-40ee-9947-839d685cecfe/downloadRevista Portuguesa de Cardiologia (English Edition)371110
spellingShingle The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
Cardim, Nuno
Hypertrophic cardiomyopathy
Registry
Left ventricular hypertrophy
Outcome
subject.fl_str_mv Hypertrophic cardiomyopathy
Registry
Left ventricular hypertrophy
Outcome
title The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
title_full The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
title_fullStr The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
title_full_unstemmed The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
title_short The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
title_sort The Portuguese Registry of Hypertrophic Cardiomyopathy : overall results
topic Hypertrophic cardiomyopathy
Registry
Left ventricular hypertrophy
Outcome
topic_facet Hypertrophic cardiomyopathy
Registry
Left ventricular hypertrophy
Outcome
url http://hdl.handle.net/10451/34944
visible 1